Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Fintech PR

SANY’s Commitment to Carbon Neutrality: Paving the Way for a Sustainable Future




SHANGHAI, Feb. 28, 2024 /PRNewswire/ — On January 26th, the first International Clean Energy Day, as proclaimed by the United Nations, was observed globally, highlighting the crucial role clean energy plays in fostering a sustainable energy transition. SANY Group (“SANY”) is actively participating in this drive by providing integrated solutions for clean energy operations and driving green industrial transformation.

SANY prioritizes the development of energy-saving technologies and offers highly efficient, low-energy consumption products, making notable progress in hybrid, electric, hydrogen fuel, wind power, and prefabricated construction:

  • SANY operates 26 wind farms across 18 Chinese provinces.
  • SANY’s 176 electrified products have reduced emissions by 4,150,489 tons.
  • SANY’s hydrogen refueling stations use alkaline electrolysis with a maximum current density of 8000A/㎡, operating at 35Mpa pressure, and refueling at a speed of 5kg/min.
  • SANY’s silicon energy division has produced a 5.5-meter monocrystalline silicon rod.

The total investment of the wind hydrogen storage business in the next three years is expected to be 5.1 billion USD, of which wind energy is 2.7 billion, photovoltaic 2.1 billion, hydrogen energy 90 million, energy storage, and lithium 210 million.

Each section plans sales of 11.3 billion USD per year and profits of 1 billion USD per year in the next three years.

SANY Renewable Energy: Committed to High-Quality Wind Power Equipment

In 2024, SANY will collaborate with customers to build 10 fault-free benchmark wind farms in China, integrating smart solutions for high-quality operations throughout the lifecycle.

For two consecutive years, SANY Renewable Energy’s SI-230100 wind turbine has been recognized as a top onshore wind turbine by Windpower Monthly, receiving the coveted gold prize.

Additionally, SANY Renewable Energy recently achieved another milestone by producing the SY1310A blade, measuring 131 meters, at its zero-carbon intelligent industrial park in Bayannur, Inner Mongolia, setting a new world record for the longest onshore wind turbine blade.

SANY Electrification: Leading the Way in Electric Construction Machinery

SANY’s electrified products have over 80% global market share, and it has also partnered with major port operators like PSA, APMT, Hutchison, and DPW to promote environmentally friendly port logistics.

“There is a growing environmental consciousness, and our company is committed to reducing energy consumption and production greenhouse gas emissions. This makes me passionate about these issues and motivates me to contribute to society,” said Ashley Law, an engineer at SANY’s R&D Center in Germany. “We aim to use innovation and technology to address various social issues in modern urban construction,” Law added.

Moreover, SANY Group participated in China’s first electrified highway project in Zhuzhou, Hunan. In 2023, their Mota 1165 electric tractor set a record by traveling over 800 km from Changsha to Shenzhen in just over 13 hours on a single charge.

SANY Hydrogen: Delivering Zero-Carbon Solutions through Integrated Hydrogen Refueling Stations and Equipment

In 2020, SANY produced the world’s first hydrogen fuel cell mixer truck and dump truck, marking a significant milestone in the hydrogen era.

In 2022, SANY established the first integrated hydrogen production and refueling station in Hunan, China, expanding its presence in the hydrogen energy supply chain.

In 2023, SANY Hydrogen signed a strategic cooperation agreement with Guangtai Hydrogen Energy Technology to build the first 2000kg-class hydrogen refueling station in Shanghai, representing the first commercial deployment of SANY’s integrated hydrogen refueling station solution.

Furthermore, SANY Hydrogen achieved breakthroughs with a 1.5GW production line for alkaline electrolyzers, enabling mass production of systems from 500 to 2000 standard cubic meters, and built a 20MW-scale electrolyzer test platform for product development.

SANY Silicon Energy: Driving Innovation and Industrialization in Photovoltaic Sector

SANY Group is rapidly developing the monocrystalline silicon photovoltaic industry, from silicon rods to cell production and photovoltaic module manufacturing, aiming to create a new industry hub in the central and western regions of China.

In 2023, SANY Silicon Energy achieved mass production of its first N-type TOPCon solar cells at its 5GW Zhuzhou facility, completing its integrated industry footprint. The project also saw the successful production of the first monocrystalline silicon rod at SANY Silicon Energy’s Shuozhou facility, providing a strong impetus for future industry-scale deployment.

SANY is committed to the energy transition in mining and construction, recognizing no one-size-fits-all solutions. It tailors approaches, empowering customers with confidence on their journeys towards a low-carbon future.

Visit SANY on LinkedIn:



Photo –
Logo – 

Cision View original content:

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024




STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting

The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision,c3956826

The following files are available for download:

Invitation to presentation of EQT AB’s Q1 Announcement 2024,c3285895

EQT AB Group


View original content:

Continue Reading

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs



  • Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
  • Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
  • Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
    • Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
    • PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
  • Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
  • 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
  • CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”

Photo –

Cision View original content to download multimedia:

Continue Reading

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update




VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.

BioVaxys Technology Corp. (, a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit and connect with us on X and LinkedIn.


Signed “James Passin
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo –

Cision View original content:

Continue Reading